ClinicalTrials.Veeva

Menu

Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy

O

Ospedale Misericordia e Dolce

Status and phase

Completed
Phase 4

Conditions

Contrast-Induced Nephropathy

Treatments

Drug: Sodium Bicarbonate
Drug: Isotonic Saline

Study type

Interventional

Funder types

Other

Identifiers

NCT00606827
Prato0701
POCARD0701

Details and patient eligibility

About

Contrast-induced nephrophaty (CIN) accounts for more than 10% of hospital-acquired renal failure. Hydration with sodium bicarbonate is more protective than isotonic saline in animals. Limited data are available in humans. We compared the efficacy of sodium bicarbonate versus isotonic saline to prevent CIN in a large population of patients with renal dysfunction undergoing coronary angiography or intervention.

Enrollment

500 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with creatinine clearance < 60 mL/min

Exclusion criteria

  • contrast medium administration within the previous 10 days
  • end-stage renal failure requiring dialysis
  • refusal to give informed consent

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

500 participants in 2 patient groups

A
Experimental group
Description:
Bicarbonate
Treatment:
Drug: Sodium Bicarbonate
B
Active Comparator group
Description:
Saline
Treatment:
Drug: Isotonic Saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems